# Sangamo Therapeutics, Inc: Form DEF 14A, filed Apr 19, 2024

- Company: [Sangamo Therapeutics, Inc](/companies/sgmoq.md) (CIK 1001233)
- Form: DEF 14A
- Filed: 2024-04-19
- Accepted by EDGAR: Apr 19, 2024, 16:01 ET
- Period: 2024-06-04
- Accession: 0001628280-24-016932
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1001233/000162828024016932/sgmo-20240419.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1001233/000162828024016932/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1001233/000162828024016932/sgmo-20240419.htm

Filed Apr 19, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-016932. Last ingested by Listed: Oct 27, 2026, 16:02 ET. No prices; not investment advice.